Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001529793 | SCV000714147 | likely benign | not provided | 2020-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001529793 | SCV002399296 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341541 | SCV002638209 | likely benign | Cardiovascular phenotype | 2019-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000613180 | SCV005039875 | likely benign | not specified | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529793 | SCV001743878 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000613180 | SCV001925435 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529793 | SCV001958306 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529793 | SCV001963815 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004543406 | SCV004768445 | likely benign | ALPK3-related disorder | 2020-08-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |